Contact
Please use this form to send email to PR contact of this press release:
Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study
TO:
Please use this form to send email to PR contact of this press release:
Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study
TO: